1-10 of 10
R Caballero
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract P5-12-03: Genome copy number entropy as predictor of response for neoadjuvant therapy in early breast cancer

E Alba, OM Rueda, A Lluch, J Albanell, S-F Chin, JI Chacón, L Calvo, J De la Haba-Rodriguez, B Bermejo, N Ribelles, P Sánchez-Rovira, A Plazaola, A Barnadas, B Cirauqul, M Ramos, A Arcusa, E Carrasco, J Herranz, M Chiesa, R Caballero, A Santonja, F Rojo, C Caldas
Journal: Cancer Research
Cancer Res (2019) 79 (4_Supplement): P5-12-03.
DOI: https://doi.org/10.1158/1538-7445.SABCS18-P5-12-03
Published: 15 February 2019
View article
Journal Articles

Abstract P5-21-23: Evaluation of the drug interaction potential of palbociclib and exemestane – Results from the PEARL pharmacokinetic sub-Study

M Martín, J Hoffman, M Ruiz-Borrego, M Muñoz, L Calvo, P Crownover, JA García-Sáenz, E Alba, D Wang, C Thallinger, A Stradella, Á Montaño, B Adamo, S Antolín, F Moreno-Antón, C Falo, V Ruiz, N Martín, R Caballero, E Carrasco, M Gil-Gil
Journal: Cancer Research
Cancer Res (2018) 78 (4_Supplement): P5-21-23.
DOI: https://doi.org/10.1158/1538-7445.SABCS17-P5-21-23
Published: 15 February 2018
View article
Journal Articles

Abstract OT1-01-02: A multicenter phase II trial to evaluate the efficacy and safety of pembrolizumab and gemcitabine in patients with HER2-negative advanced breast cancer: GEICAM/2015-04 PANGEA-Breast

L de la Cruz, V Sánchez-Margalet, P Berraondo, S Benito, MJ Escudero, R Caballero, E Carrasco, L Galluzzi, F Rojo
Journal: Cancer Research
Cancer Res (2018) 78 (4_Supplement): OT1-01-02.
DOI: https://doi.org/10.1158/1538-7445.SABCS17-OT1-01-02
Published: 15 February 2018
View article
Journal Articles

Abstract OT3-02-07: A phase II study to compare fulvestrant (F) 500mg plus placebo versus (vs) F 500mg plus palbociclib (P) as first line treatment for postmenopausal women with hormone receptor (HR)-positive advanced breast cancer (BC) sensitive to endocrine therapy (ET). “The FLIPPER study” (GEICAM/2014-12)

F Moreno, N Martínez-Jañez, I Garau, JA Guerra, J Alarcón, B Bermejo, L Gonzalez-Cortijo, C Bueno, J Lao, S Bezares, L Rosell, A Blanch, R Caballero, E Carrasco, F Rojo, M Martín, M O'Connor, A Hernando, J Albanell
Journal: Cancer Research
Cancer Res (2017) 77 (4_Supplement): OT3-02-07.
DOI: https://doi.org/10.1158/1538-7445.SABCS16-OT3-02-07
Published: 15 February 2017
View article
Journal Articles

Abstract P3-07-42: Predicting outcome and benefit to first-line bevacizumab in advanced/metastatic hormone receptor (HR)+/HER2-negative breast cancer (BC) treated with endocrine therapy: A correlative science study from the LEA phase III clinical trial (GEICAM/2006-11_GBG 051)

A Prat, J de la Haba-Rodriguez, Á Guerrero, JA García-Sáenz, S Morales, A Antón, M Muñoz, M Ramos, N Martínez-Jáñez, M Margelí, S Servitja, F Rojo, P Galván, S González, J Cruz, P Sánchez-Rovira, A Perelló, C Rodríguez-Martin, M Casas, E Carrasco, R Caballero, M Martín
Journal: Cancer Research
Cancer Res (2016) 76 (4_Supplement): P3-07-42.
DOI: https://doi.org/10.1158/1538-7445.SABCS15-P3-07-42
Published: 15 February 2016
View article
Journal Articles

Abstract P6-05-02: Intrinsic subtype and gene expression changes between primary and metastatic breast cancer

A Prat, E Martínez de Dueñas, P Galván, S Garcia, O Burgués, L Paré, S Antolín, R Martinello, I Blancas, B Adamo, Á Guerrero, M Muñoz, P Nuciforo, M Vidal, RM Pérez, JI Chacón, R Caballero, P Gascón, E Carrasco, F Rojo, CM Perou, J Cortés, V Adamo, J Albanell, A Lluch
Journal: Cancer Research
Cancer Res (2016) 76 (4_Supplement): P6-05-02.
DOI: https://doi.org/10.1158/1538-7445.SABCS15-P6-05-02
Published: 15 February 2016
View article
Journal Articles

Abstract OT3-01-02: A phase I-II trial of dasatinib in combination with trastuzumab (T) and paclitaxel in the first line treatment of HER2 positive metastatic breast cancer (MBC) patients: GEICAM/2010-04

A Ocaña, M Ruiz Borrego, M Gil-Martín, S Antolín, Á Guerrero, L Vidal Boixader, M Martín, JM Trigo Pérez, F Rojo, Y Jerez, M Atienza, S Pernas, A Hernando, E Carrasco, S Benito, R Caballero, A Pandiella
Journal: Cancer Research
Cancer Res (2016) 76 (4_Supplement): OT3-01-02.
DOI: https://doi.org/10.1158/1538-7445.SABCS15-OT3-01-02
Published: 15 February 2016
View article
Journal Articles

Abstract P2-11-06: Comparison of PAM50 risk of recurrence (ROR) scores with EndoPredict for predicting risk of distant metastasis in ER+/HER2-, early node-positive breast cancer patients treated with adjuvant chemotherapy - A GEICAM/ 9906 sub-study

M Martin, JC Brase, CM Perou, A Ruiz, A Prat, KE Weber, L Calvo, C Petry, PS Bernard, M Ruiz-Borrego, R Kronenwett, AM Santaballa, CA Rodriguez, IM Alvarez, MA Segui, M Casas, E Carrasco, R Caballero, A Rodriguez-Lescure
Journal: Cancer Research
Cancer Res (2013) 73 (24_Supplement): P2-11-06.
DOI: https://doi.org/10.1158/0008-5472.SABCS13-P2-11-06
Published: 15 December 2013
View article
Journal Articles

Abstract P2-10-11: Prognostic performance of the EndoPredict score in node-positive chemotherapy-treated ER+/HER2− breast cancer patients: results from the GEICAM/9906 trial.

M Martin, JC Brase, M Ruiz-Borrego, K Krappmann, B Munarriz, K Fisch, A Ruiz, KE Weber, C Crespo, C Petry, CA Rodriguez, R Kronenwett, L Calvo, E Alba, E Carrasco, M Casas, R Caballero, A Rodriguez-Lescure
Journal: Cancer Research
Cancer Res (2012) 72 (24_Supplement): P2-10-11.
DOI: https://doi.org/10.1158/0008-5472.SABCS12-P2-10-11
Published: 15 December 2012
View article
Journal Articles

P1-06-04: PAM50 Proliferation Index Predicts Response to Weekly Adjuvant Paclitaxel in Node-Positive Operable Breast Cancer.

M Martín, Á Rodríguez-Lescure, IJ Stijleman, B Munárriz, M Ruíz-Borrego, C Davis, C Crespo, CA Rodríguez, MTW Ebbert, I Álvarez, V Furió, RRL Bastien, AM García, MC Cheang, J Palacios, MJC Ellis, E Carrasco, MI Casas, R Caballero, CM Perou, PS Bernard
Journal: Cancer Research
Cancer Res (2011) 71 (24_Supplement): P1-06-04.
DOI: https://doi.org/10.1158/0008-5472.SABCS11-P1-06-04
Published: 15 December 2011
View article